Dynavax Technologies Corp (DVAX)
11.17
-0.25
(-2.19%)
USD |
NASDAQ |
Apr 25, 16:00
11.16
0.00 (0.00%)
Pre-Market: 20:00
Dynavax Technologies Free Cash Flow: 96.46M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 96.46M |
| September 30, 2023 | 117.78M |
| June 30, 2023 | 147.27M |
| March 31, 2023 | 133.72M |
| December 31, 2022 | 55.58M |
| September 30, 2022 | 139.68M |
| June 30, 2022 | 141.98M |
| March 31, 2022 | 237.96M |
| December 31, 2021 | 326.05M |
| September 30, 2021 | 192.08M |
| June 30, 2021 | 101.41M |
| March 31, 2021 | -30.82M |
| December 31, 2020 | -103.32M |
| September 30, 2020 | -111.65M |
| June 30, 2020 | -114.73M |
| March 31, 2020 | -136.09M |
| December 31, 2019 | -150.65M |
| September 30, 2019 | -160.79M |
| June 30, 2019 | -166.20M |
| March 31, 2019 | -157.00M |
| December 31, 2018 | -146.49M |
| September 30, 2018 | -129.55M |
| June 30, 2018 | -110.24M |
| March 31, 2018 | -92.97M |
| December 31, 2017 | -78.19M |
| Date | Value |
|---|---|
| September 30, 2017 | -87.67M |
| June 30, 2017 | -100.22M |
| March 31, 2017 | -110.55M |
| December 31, 2016 | -114.81M |
| September 30, 2016 | -111.86M |
| June 30, 2016 | -107.63M |
| March 31, 2016 | -104.52M |
| December 31, 2015 | -99.53M |
| September 30, 2015 | -92.29M |
| June 30, 2015 | -90.08M |
| March 31, 2015 | -88.59M |
| December 31, 2014 | -75.40M |
| September 30, 2014 | -70.23M |
| June 30, 2014 | -59.60M |
| March 31, 2014 | -52.46M |
| December 31, 2013 | -60.30M |
| September 30, 2013 | -56.94M |
| June 30, 2013 | -56.87M |
| March 31, 2013 | -57.05M |
| December 31, 2012 | -46.74M |
| September 30, 2012 | -43.81M |
| June 30, 2012 | -43.99M |
| March 31, 2012 | -37.74M |
| December 31, 2011 | -48.26M |
| September 30, 2011 | -60.56M |
Free Cash Flow Range, Past 5 Years
-166.20M
Minimum
Jun 2019
326.05M
Maximum
Dec 2021
37.67M
Average
96.46M
Median
Dec 2023
Free Cash Flow Benchmarks
| Supernus Pharmaceuticals Inc | 110.53M |
| Ligand Pharmaceuticals Inc | -4.272M |
| Pacira BioSciences Inc | 139.49M |
| Esperion Therapeutics Inc | -135.49M |
| PetIQ Inc | 52.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 13.77M |
| Cash from Investing (Quarterly) | -20.24M |
| Cash from Financing (Quarterly) | 1.776M |
| Free Cash Flow Per Share (Quarterly) | 0.0931 |
| Free Cash Flow to Equity (Quarterly) | 11.76M |
| Free Cash Flow to Firm (Quarterly) | 12.04M |
| Free Cash Flow Yield | 6.13% |